Market Tracker

09/22 5:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.70
Delayed Data
As of 3:59pm ET
 +0.02 / +1.19%
Today’s Change
1.47
Today|||52-Week Range
4.69
-32.00%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close1.68
Today’s open1.70
Day’s range1.65 - 1.73
Volume73,477
Average volume (3 months)186,695
Market cap$33.7M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...0.000.00%
CTRVContraVir Pharmaceut...+0.00+0.57%
PPHMPPeregrine Pharmaceut...-0.03-0.15%
PRPHProPhase Labs Inc+0.02+0.89%
Data as of 4:09pm ET, 09/22/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts